Welcome to our dedicated page for Dalrada Financl news (Ticker: DFCO), a resource for investors and traders seeking the latest updates and insights on Dalrada Financl stock.
Dalrada Financial Corporation (DFCO) delivers innovative solutions across clean energy, healthcare, and advanced manufacturing. This news hub provides investors and industry professionals with essential updates on the company’s strategic initiatives and market developments.
Access real-time announcements including earnings reports, product launches, and partnership agreements. Track progress in low-carbon heating systems, healthcare diagnostics, and deposition technology innovations. Our curated feed ensures you stay informed about DFCO’s contributions to sustainable energy and medical advancements.
Discover updates from key subsidiaries like Genefic Specialty Pharmacy and Deptec’s thin-film deposition systems. Content spans regulatory filings, technology patents, and operational expansions. All materials are sourced directly from verified corporate communications.
Bookmark this page for streamlined access to DFCO’s latest milestones. Check back regularly for unfiltered insights into the company’s multi-sector progress and industry leadership.
Dalrada Financial (OTCQB:DFCO) CEO Brian Bonar shared insights and updates in a new interview with SmallCapVoice. Key highlights include:
- Bonar's CEO of the Year Award from San Diego Business Journal
- Opportunities in New York City due to Local Law 97
- Dalrada's appointment to the Minority Business RoundTable (MBRT)
Bonar discussed the potential impact of NYC's Local Law 97, which aims to reduce greenhouse gas emissions in buildings. He noted that Dalrada's heat pump technology could capture a significant market share in replacing gas boilers, potentially generating $60 million in revenue over 18 months with just 1% market penetration. Bonar also anticipates revenue from government opportunities through MBRT starting in the first quarter of next year.
Dalrada Financial (OTCQB: DFCO) has been invited to join the Minority Business RoundTable (MBRT), a prestigious nonprofit organization led by Roger Campos. This membership allows Dalrada unique access to business opportunities in public, private, and government sectors, enhancing its influence and reach globally. Dalrada’s gold-level sponsorship underscores its commitment to a lasting partnership with MBRT. CEO Brian Bonar highlighted the potential for increased awareness and credibility among policymakers, while Campos praised Dalrada's innovative contributions to local and global economies. This strategic move aligns with Dalrada's mission to effect positive change through its technological solutions in climate and healthcare.
Dalrada Financial (OTCQB: DFCO) announced that its healthcare subsidiary, Genefic, has acquired IV Services, , a leading pharmaceutical and infusion management company. This acquisition strengthens Genefic’s market position by expanding its sales and operational footprint, increasing top-line revenue, and enhancing patient care capabilities. The acquisition is non-dilutive to shareholders and allows Genefic to enter the $42 billion global infusion pharmacy management market, which is expected to grow to $70 billion by 2030. Genefic gains new regional presence in Louisiana and Mississippi, complementing its existing operations in several other U.S. states.
Dalrada Financial (OTCQB: DFCO) filed a Form 10-Q for Q3 2024, revealing a revenue of $10.3 million, driven primarily by its pharmaceutical subsidiary, Genefic Specialty Pharmacy. Genefic accounted for $8.6 million, an 80% increase from Q3 2023 and a 95.5% rise from the previous quarter. The company also converted $13.3 million of affiliate debt to Series I preferred shares, reducing net losses to $2.9 million, the lowest since 2021. CEO Brian Bonar emphasized ongoing efforts to clear debt and reduce expenditures, with a net equity of $8.8 million. Dalrada anticipates continued growth in Q4 and a year-over-year revenue increase by the end of fiscal 2024.
FAQ
What is the current stock price of Dalrada Financl (DFCO)?
What is the market cap of Dalrada Financl (DFCO)?
